ImportRefusal LogoImportRefusal

Ipsen Limited

⚠️ Moderate Risk

FEI: 3003789673 • Slough • UNITED KINGDOM

FEI

FEI Number

3003789673

📍

Location

Slough

🇬🇧
🏢

Address

190 Bath Road, , Slough, , United Kingdom

Moderate Risk

FDA Import Risk Assessment

49.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
12/9/2024
Latest Refusal
3/23/2010
Earliest Refusal

Score Breakdown

Violation Severity
74.0×40%
Refusal Volume
22.3×30%
Recency
63.1×20%
Frequency
2.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

711×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

Refusal History

DateProductViolationsDivision
12/9/2024
58PCY05ONABOTULINUMTOXINA
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/22/2017
65QCK02BOTOX
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2010
65QCK02BOTOX
71NO LICENSE
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Ipsen Limited's FDA import refusal history?

Ipsen Limited (FEI: 3003789673) has 3 FDA import refusal record(s) in our database, spanning from 3/23/2010 to 12/9/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Ipsen Limited's FEI number is 3003789673.

What types of violations has Ipsen Limited received?

Ipsen Limited has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Ipsen Limited come from?

All FDA import refusal data for Ipsen Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.